000 02384 a2200649 4500
005 20250513200649.0
264 0 _c20000214
008 200002s 0 0 eng d
022 _a1042-8194
024 7 _a10.1080/10428199909169612
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSacchi, S
245 0 0 _aUnexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cNov 1999
300 _a483-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aAtaxia
_xchemically induced
650 0 4 _aCombined Modality Therapy
_xadverse effects
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFemur Head Necrosis
_xchemically induced
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadministration & dosage
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aLeukocytosis
_xchemically induced
650 0 4 _aLife Tables
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParanoid Disorders
_xchemically induced
650 0 4 _aPilot Projects
650 0 4 _aPseudotumor Cerebri
_xchemically induced
650 0 4 _aPulmonary Edema
_xchemically induced
650 0 4 _aRed-Cell Aplasia, Pure
_xchemically induced
650 0 4 _aRemission Induction
650 0 4 _aSurvival Analysis
650 0 4 _aSyncope
_xchemically induced
650 0 4 _aTreatment Outcome
650 0 4 _aTretinoin
_xadministration & dosage
700 1 _aKantarjian, H M
700 1 _aFreireich, E J
700 1 _aO'Brien, S
700 1 _aCortes, J
700 1 _aRios, M B
700 1 _aKornblau, S
700 1 _aGiles, F J
700 1 _aKoller, C
700 1 _aGajewski, J
700 1 _aTalpaz, M
773 0 _tLeukemia & lymphoma
_gvol. 35
_gno. 5-6
_gp. 483-9
856 4 0 _uhttps://doi.org/10.1080/10428199909169612
_zAvailable from publisher's website
999 _c10565761
_d10565761